FDA okays cuffless BP monitor

November 15, 2019 0 By FM

The US FDA has granted a 510K clearance for Patch and Watch for measurement of blood pressure, oxygenation and heart rate in hospitals, clinics, long-term care and at home.

Biobeat’s smartwatch and patch connect to the cloud through either a smartphone or a dedicated gateway. The user will use one or the other device; whereas the watch is worn on the wrist, the patch is to be placed anywhere on the upper torso.

Biobeat is a revenue-stage company located in Israel. The company’s sensors are based on the company’s exceptional proprietary technologies in the field of reflective Plethysmography (PPG). It is focusing on wireless medical-grade products that allow health providers to care as efficiently for patients outside of their facility as on-site.